C57BL/6NTac-Tcf7l2tm1a(EUCOMM)Wtsi/WtsiIeg

Status

Available to order

EMMA IDEM:07858
International strain nameC57BL/6NTac-Tcf7l2tm1a(EUCOMM)Wtsi/WtsiIeg
Alternative nameEPD0157_5_B10
Strain typeTargeted Mutant Strains
Allele/Transgene symbolTcf7l2tm1a(EUCOMM)Wtsi
Gene/Transgene symbolTcf7l2
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider Wellcome Trust Sanger Institute
Provider affiliationWellcome Trust Sanger Institute
Genetic informationThis mouse line originates from EUCOMM ES clone EPD0157_5_B10. For further details on the construction of this clone see the page at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreHelmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany
Animals used for archivingheterozygous C57BL/6NTac

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (allele matching)
  • increased bone mineral density / IMPC
  • increased mean platelet volume / IMPC
  • increased lean body mass / IMPC
  • decreased total body fat amount / IMPC
  • increased red blood cell distribution width / IMPC
  • increased bone mineral content / IMPC
  • preweaning lethality, complete penetrance / IMPC
IMPC phenotypes (gene matching)
  • increased lean body mass / IMPC
  • increased mean platelet volume / IMPC
  • increased red blood cell distribution width / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • increased bone mineral density / IMPC
  • increased bone mineral content / IMPC
  • decreased total body fat amount / IMPC
MGI phenotypes (allele matching)
  • abnormal glucose homeostasis / MGI
  • abnormal response/metabolism to endogenous compounds / MGI
  • impaired glucose tolerance / MGI
  • increased circulating glucose level / MGI
  • abnormal hepatocyte physiology / MGI
  • lethality, complete penetrance / MGI
  • double outlet right ventricle / MGI
  • absent kidney / MGI
  • enlarged liver sinusoidal spaces / MGI
  • abnormal forebrain morphology / MGI
  • abnormal nasal septum morphology / MGI
  • abnormal eye muscle morphology / MGI
  • abnormal Mullerian duct morphology / MGI
  • abnormal Wolffian duct morphology / MGI
  • retroesophageal right subclavian artery / MGI
  • abnormal neurohypophysis morphology / MGI
  • basisphenoid bone foramen / MGI
  • vertebral fusion / MGI
  • fusion of vertebral arches / MGI
  • abnormal inferior vena cava morphology / MGI
  • perimembraneous ventricular septal defect / MGI
  • muscular ventricular septal defect / MGI
  • common truncal valve / MGI
  • abnormal pulmonary valve cusp morphology / MGI
  • abnormal umbilical vein morphology / MGI
  • abnormal vertebral artery morphology / MGI
  • abnormal basilar artery morphology / MGI
  • abnormal cecum position / MGI
  • absent ductus venosus valve / MGI
  • abnormal ureter topology / MGI
  • abnormal elbow joint morphology / MGI
  • symmetric azygos veins / MGI
  • abnormal umbilical vein topology / MGI
  • abnormal vertebral artery topology / MGI
  • heterochrony / MGI
MGI phenotypes (gene matching)
  • hypoglycemia / MGI
  • double outlet right ventricle / MGI
  • decreased enterocyte cell number / MGI
  • abnormal intestine morphology / MGI
  • abnormal enterocyte morphology / MGI
  • abnormal intestinal epithelium morphology / MGI
  • abnormal crypts of Lieberkuhn morphology / MGI
  • abnormal colon morphology / MGI
  • abnormal small intestine morphology / MGI
  • absent kidney / MGI
  • enlarged liver sinusoidal spaces / MGI
  • enlarged pituitary gland / MGI
  • abnormal forebrain morphology / MGI
  • decreased body weight / MGI
  • hypoactivity / MGI
  • polyphagia / MGI
  • abnormal glucose homeostasis / MGI
  • abnormal nasal septum morphology / MGI
  • decreased circulating insulin level / MGI
  • abnormal intestinal goblet cell morphology / MGI
  • abnormal response/metabolism to endogenous compounds / MGI
  • abnormal eye muscle morphology / MGI
  • abnormal Mullerian duct morphology / MGI
  • abnormal Wolffian duct morphology / MGI
  • abnormal craniofacial development / MGI
  • decreased lean body mass / MGI
  • retroesophageal right subclavian artery / MGI
  • abnormal neurohypophysis morphology / MGI
  • basisphenoid bone foramen / MGI
  • vertebral fusion / MGI
  • fusion of vertebral arches / MGI
  • improved glucose tolerance / MGI
  • impaired glucose tolerance / MGI
  • homeostasis/metabolism phenotype / MGI
  • cellular phenotype / MGI
  • increased circulating glucose level / MGI
  • decreased circulating glucose level / MGI
  • abnormal inferior vena cava morphology / MGI
  • abnormal pituitary intermediate lobe morphology / MGI
  • enlarged adenohypophysis / MGI
  • abnormal enterocyte proliferation / MGI
  • absent gastric milk in neonates / MGI
  • decreased birth weight / MGI
  • decreased birth body size / MGI
  • decreased total body fat amount / MGI
  • abnormal hepatocyte physiology / MGI
  • perimembraneous ventricular septal defect / MGI
  • muscular ventricular septal defect / MGI
  • common truncal valve / MGI
  • abnormal pulmonary valve cusp morphology / MGI
  • abnormal intestinal enteroendocrine cell morphology / MGI
  • neonatal lethality, complete penetrance / MGI
  • lethality, complete penetrance / MGI
  • abnormal vertebral artery morphology / MGI
  • abnormal basilar artery morphology / MGI
  • embryo tissue necrosis / MGI
  • abnormal small intestine goblet cell morphology / MGI
  • abnormal colon goblet cell morphology / MGI
  • abnormal cecum position / MGI
  • absent ductus venosus valve / MGI
  • duplication of ductus venosus / MGI
  • abnormal ureter topology / MGI
  • abnormal elbow joint morphology / MGI
  • symmetric azygos veins / MGI
  • abnormal umbilical vein topology / MGI
  • abnormal vertebral artery topology / MGI
  • heterochrony / MGI
  • abnormal inferior vena cava topology / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).